haloperidol decanoate has been researched along with d-alpha tocopherol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bošković, M; Grabnar, I; Koprivšek, J; Plesničar, BK; Vovk, T | 1 |
1 review(s) available for haloperidol decanoate and d-alpha tocopherol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for haloperidol decanoate and d-alpha tocopherol
| Article | Year |
|---|---|
Vitamin E and essential polyunsaturated fatty acids supplementation in schizophrenia patients treated with haloperidol.
Topics: Administration, Oral; Adult; Antioxidants; Antipsychotic Agents; Biomarkers; Combined Modality Therapy; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Dietary Supplements; Double-Blind Method; Fatty Acids, Essential; Fatty Acids, Omega-3; Haloperidol; Humans; Male; Middle Aged; Oleic Acid; Oxidative Stress; Pilot Projects; Psychiatric Status Rating Scales; Schizophrenia; Vitamin E | 2016 |